|
Frontier Pharma: Systemic Lupus Erythematosus – Identifying and …
PR Newswire (press release) … Benlysta (belimumab), generated sales of $111m in 2012, there is little evidence that the drug’s performance is significantly superior to other B-cell targeted therapies such as Rituxan (rituximab), which is often used off-license to treat … |
|
Immune Drug Helps Relapsing Kidney Disease
Ivanhoe (Ivanhoe Newswire) –A recent study shows that in patients with a frequently-relapsing form of kidney disease, relapses decreased approximately five-fold for at least one year after patients took a single dose of rituximab. For many patients with a … |
Genetic Engineering NewsTop 10 Clinical Trial Failures of 2013Genetic Engineering NewsHow it failed: Did not meet primary endpoint of showing a statistically significant increase compared to placebo in disease-free survival in patients at high risk of …
Daily Mail |
‘Some mornings I’m in so much pain Nicky has to dress me’: Girlfriend of …
Daily Mail ‘Rituximab is like gold dust and costs about £5,000 per infusion via the NHS so I’m really grateful to have it, and it is helping as I have noticed some of my symptoms ease slightly since my second infusion,’ she says. She met Nicky, 55, when she … |
Drug Discovery & Development |
EU Committee Backs New Form of Roche Cancer Drug
Drug Discovery & Development Roche announced that the EU Committee for Medicinal Products for Human Use (CHMP) recommended that the European Commission approve MabThera (rituximab) 1400mg solution for subcutaneous (SC) injection for the treatment of patients with common … |
India.Com Health |
Leukemia pill ‘can melt away’ cancer cells
Medical News Today Rituximab and idelalsib, or; Rituximab and a placebo pill. The researchers found that compared with the group who received rituximab and a placebo pill, patients who received rituximab and idelalsib avoided disease progression for a longer period of time. Treatment of leukemia – Pills to replace chemotherapy?India.Com Health |
|
BioLineRx’s BL-8040 receives US orphan drug status for stem cell mobilization …
pharmabiz.com Pre-clinical studies show that BL-8040 is efficient, both alone and in combination with the anti-cancer drug Rituximab, in reducing bone marrow metastasis of lymphoma cells and stimulating lymphoma cell death. BL-8040 also mobilizes stem cells from the … |
India.Com HealthTreatment of leukemia – Pills to replace chemotherapy?India.Com HealthThey found that those who received the combination of idelalsib and rituximab went longer without their disease worsening than those who received only rituximab, whic…
New drug shows promise in treating indolent non-Hodgkin lymphomasFred Hutchinson Cancer Research Center NewsAbout 20,000 people in the United States were diagnosed with iNHL in 2012 and approximately 7,000 died of the disease. The standard treatment fo…
Financial Express |
Pill ‘melts away’ common form of leukaemia
Business Standard They found that those who received the combination of idelalsib and rituximab went longer without their disease worsening than those who received only rituximab, which has been the standard of care. Six months into the study, cancers in 93 per cent of … A pill may replace chemotherapy in treating leukemiaDaijiworld.com New pill can ‘melt away’ leukemia without chemotherapyDaily News & Analysis |